Advertisement

#non-small-cell lung cancer

An Unexpected Lung Cancer Diagnosis Reshaped Laura Greco’s World

Keytruda Plus Chemotherapy Improves Lung Cancer Survival

Lung Cancer 101

An Unexpected Lung Cancer Diagnosis Reshaped Laura Greco’s World

Keytruda Plus Chemotherapy Improves Lung Cancer Survival

Lung Cancer 101

Keytruda

Now Approved

These are the latest cancer treatments approved by the FDA.

Opdivo

Active Cancer, Recent Chemo Linked to Higher COVID-19 Death Rates

Data from a large COVID-19 and cancer registry also showed that hydroxychloroquine plus azithromycin is associated with higher mortality.

Tecentriq (atezolizumab)

Tecentriq

FDA Approves Cyramza Plus Tarceva for First-Line Lung Cancer Treatment

Ramucirumab slowed disease progression more than a placebo when added to erlotinib.

Cyramza

Generic image

Lung Cancer Medications

Here’s a list of the approved drugs to treat lung cancer. Click on any of the medications for more info on dosing, side effects and d...

FDA Approves Alunbrig for ALK-Positive Metastatic Non-Small-Cell Lung Cancer

Study showed 74% overall response rate for people who used brigatinib as their first ALK inhibitor.

Alunbrig

FDA Approves Tecentriq for First-Line Treatment of Metastatic Lung Cancer

Initial treatment with atezolizumab led to longer overall survival in people with high biomarker levels.

FDA Approves Opdivo Plus Yervoy for Lung Cancer With PD-L1 Expression

The combination led to improved overall survival compared with chemotherapy.

Cancer treatment

FDA Approves RET Inhibitor Retevmo for Lung and Thyroid Cancer

Selpercatinib, the first drug in its class, shrank tumors in over two thirds of previously treated patients.

Retevmo

FDA Approves Tabrecta for Metastatic Non-Small Cell Lung Cancer

Capmatinib shrank tumors in 68% of people with metastatic non-small-cell lung cancer with a specific MET mutation.

Tabrecta

Advertisement